Skip to main content
. 2021 May 5;2021(5):CD013540. doi: 10.1002/14651858.CD013540.pub2

Han 2008.

Study characteristics
Methods Design: retrospective cohort
Setting: community
Country: USA
Duration of follow‐up: 1 year
Covariates controlled for: age, education, race, living arrangement, before enrolment. history of alcohol use and smoking, and depressive symptoms, ADL function, Charlson Comorbidity Index
Participants Participants numbers: 544
Population type: older adults
Sex: 100% men
Age (mean): 74 years
Prognostic factors Anticholinergic burden measurement method: clinician‐rated
Outcomes Outcomes assessed: cognitive decline
Outcome ascertainment cognitive decline: HVRT, IADL
Diagnostic criteria cognitive decline: scores on cognitive testing
Source of funding Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine
Notes  
 
Item Authors' judgement Support for judgement
Study participation No Men only with hypertension.
Study attrition Unclear Attrition was high but just below the 20% high risk mark. Conducted analysis to investigate potential impact of missing values on final model and did not alter conclusions but did not explain what these missing data analyses entailed.
Prognostic factor measurement Unclear No measurement of dosage or frequency of use. No measurement of non‐VA sources of drugs. Conducted repeated measurements over the follow‐up period for the 12 months preceding each assessment at 1 and 2 years.
Outcome measurement Unclear No mention of blinding. Unclear if anticholinergic burden was applied before or after cognitive assessment score was determined.
Study confounding Yes Only men in sample so no sex. Controlled for comorbidities via Charlson Comorbidity Index along with depression.
Reverse causation No Anticholinergic burden exposure time frame defined as the 12 months preceding each follow‐up at 1 year and 2 years. (so seems to have covered medication use right up to the point of each follow‐up assessment).
Statistical analysis and reporting Unclear No assessment of assumptions. Referred to a protocol but was not a protocol specifically for this study so no mention of an analysis plan.